A bill for an act relating to the production and administration of psilocybin and providing penalties.
Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).
Email me when HF 2085 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HF 2085. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill creates a new chapter that allows qualified providers to recommend, dispense, and administer psilocybin for medical purposes, but only through licensed production facilities and registered therapists. It sets up licensing boards, inventory tracking, testing labs, and enforcement mechanisms, affecting growers, manufacturers, health providers, and patients. The goal is to control quality, safety, and accountability while integrating psilocybin into regulated medical care.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HF 2085
3 free questions a day, no accountHistory
- Subcommittee Meeting: 01/26/2026 12:15PM RM 305 (Cancelled).
- Subcommittee: Wilz, H., Weldon and Wilburn.
- Introduced, referred to Health and Human Services.
Sponsors
- WILLS · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HF 2085 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HF 2085 freeOr ask your AI assistant about HF 2085 directly:
Add to Claude, ChatGPT or Cursor